Hudson, MA, United States of America

Jennifer Sullivan

USPTO Granted Patents = 2 

 

Average Co-Inventor Count = 2.7

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2021-2025

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations in Gene Therapy by Jennifer Sullivan

Introduction

Jennifer Sullivan is a prominent inventor based in Hudson, MA (US). She has made significant contributions to the field of gene therapy, particularly in the development of adeno-associated virus (AAV) vectors for treating ocular and central nervous system (CNS) disorders. With a total of 2 patents, her work is paving the way for advancements in medical treatments.

Latest Patents

Jennifer Sullivan's latest patents focus on improved recombinant adeno-associated viruses (rAAV) for enhanced gene therapy. These innovations provide methods for improved transduction of retinal cells and offer new approaches for treating ocular diseases. Additionally, her patents include methods for delivering rAAV to the CNS and treating CNS disorders with improved compositions of rAAV particles. The inventions also encompass kits designed for delivering rAAV to the CNS and for treating CNS disorders.

Career Highlights

Jennifer Sullivan is currently associated with Genzyme Corporation, where she continues to innovate in the field of gene therapy. Her work has garnered attention for its potential to improve treatment outcomes for patients suffering from various ocular and CNS disorders.

Collaborations

Jennifer collaborates with notable colleagues, including Abraham Scaria and Lisa M Stanek, who contribute to her research and development efforts.

Conclusion

Jennifer Sullivan's contributions to gene therapy through her innovative patents are significant. Her work at Genzyme Corporation exemplifies the impact of dedicated inventors in advancing medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…